Lumira Ventures — 2014 Investments
2 investments dated 2014 · listed companies and verified rows first · show all
Developer of a transcatheter InterAtrial Shunt Device to treat congestive heart failure.
BiotechTewksbury, US
George J. Fazio(Executive Officer, Director)inDan B. Curtis(Executive Officer)
BoardPaul LaViolette(Director)inKevin Gillis(Director)inGerald Brunk(Director)inIrit Yaniv(Director)in
Board seatGerry Brunk· per SEC Form D
Co-investorsAccelmed PartnersGeneral CatalystSV Health InvestorsThird Rock Ventures
Aurinia is a biopharmaceutical company developing therapies for autoimmune diseases with significant unmet medical needs.
BiotechDigital HealthHealthtechMedical DevicesVictoria, US
Richard M. Glickman(Executive Officer, Director)inStephen W. Zaruby(Executive Officer, Director)Michael Martin(Executive Officer, Director)inDennis Bourgeault(Executive Officer)Mr. Tang(Chief Executive Officer and Chair of the Board)
BoardKurt von Emster(Director)in
Co-investorsNew Enterprise Associates (NEA)venBio Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




.png)





